Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 4Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 16Breast Neoplasms 14Prostatic Neoplasms 11Neoplasm Metastasis 7Lung Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Sarcoma 3Salivary Gland Neoplasms 3Histiocytoma, Malignant Fibrous 3Head and Neck Neoplasms 3Dermatofibrosarcoma 3Bone Neoplasms 3Urinary Bladder Neoplasms 2Solid Tumors 2Small Cell Lung Carcinoma 2Sarcoma, Synovial 2Rhabdomyosarcoma 2Neoplasms 2Liposarcoma 2Leiomyosarcoma 2Hemangiosarcoma 2Esthesioneuroblastoma, Olfactory 2Carcinoma, Transitional Cell 2Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Recurrent Squamous Cell Lung Carcinoma 1Pathologic Complete Response 1Ovarian Neoplasms 1

Interventions

Sunitinib 3Radiotherapy 3Cryosurgery 3pembrolizumab 2fludarabine phosphate 2Peripheral Blood Stem Cell Transplantation 2Nephrectomy 22-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2siltuximab 1avelumab 1Thalidomide 1Tacrolimus 1Suspensions 1Radiosurgery 1Radiofrequency Ablation 1Propranolol 1Powders 1PT-100 dipeptide 1Mycophenolic Acid 1Iodine 1Introns 1Interleukin-2 1Immunohistochemistry 1Genistein 1Gene Expression Profiling 1G250 monoclonal antibody 1Flow Cytometry 1Etoposide 1Docetaxel 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Kidney Neoplasms × Docetaxel × Clear all
NCT04260360 2020-08-04

Trial of NanoDoce Intratumoral Injection in Renal Cell Carcinoma

NanOlogy, LLC

Phase 1 Withdrawn
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡